Antiretroviral pharmacokinetic profile: A review of sex differences
- 1 June 2007
- journal article
- review article
- Published by Elsevier BV in Gender Medicine
- Vol. 4 (2), 106-119
- https://doi.org/10.1016/s1550-8579(07)80025-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individualsAIDS, 2003
- Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rashAIDS, 2002
- Sex differences in nevirapine rash.Clinical Infectious Diseases, 2001
- Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapyAIDS, 2001
- Sex differences in HAART-associated dyslipidaemiaAIDS, 2001
- Sex Differences in Nevirapine RashClinical Infectious Diseases, 2001
- Differences Between Women and Men in Adverse Events and CD4+ Responses to Nucleoside Analogue Therapy for HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of AmericaAIDS, 1999
- Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1994
- Human Immunodeficiency Virus Infection in North American WomenMedicine, 1991